Stryker is one of the world’s leading medical technology companies and together with our customers, we are driven to make healthcare better. The Company offers a diverse array of innovative medical technologies, including reconstructive, medical and surgical, and neurotechnology and spine products to help people lead more active and more satisfying lives. Stryker products and services are available in over 100 countries around the world. Please visit us for more information at www.stryker.com
Stryker pushes the frontiers of medical research with uncompromising clinical integrity and innovative technologies to improve the lives of patients around the world. The key to our success is based on our close relationships with our customers, which help us to understand how we can best assist them and their patients. As a trusted partner, we work directly with thousands of healthcare providers to provide the tools they need and to build best practices into everything we do.
In December 2013, Stryker completed the acquisition of MAKO Surgical Corp., a pioneer in the advancement of robotic arm assisted surgery in orthopaedics. MAKO is known for its flagship MAKOplasty Partial Knee Resurfacing procedure for treating osteoarthritis that has not progressed throughout the entire knee, and more recently for MAKOplasty Total Hip Replacement, which has demonstrated benefits in patient outcomes in more than 30,000 cases during the past five years. With MAKO’s technology platform and our innovations in joint reconstruction, we look ahead to simplifying joint reconstruction procedures and increasing the consistency, reproducibility and precision of joint surgeries, resulting in an improved patient experience.
In 2013, Stryker launched the Universal SMARTLock Hybrid MMF (maxillomandibular fixation) system, an innovation for managing facial trauma. By combining the strength and rigidity of arch bars with the safety and efficiency of MMF screws, Universal SMARTLock brings the standard of care for MMF techniques into the 21st century. Closed reduction of the jaws can be accomplished with less exposure risk to the surgeon, decreased operative time and excellent skeletal stability. An effective and technically simple process, it may change the surgical management of maxillary and mandibular fixation for all surgical specialties.
—Michael D. Turner, D.D.S., M.D., F.A.C.S.
Every 40 seconds, someone suffers a stroke, a leading cause of serious, long-term disability in the U.S. and the fourth leading cause of death. 87% of strokes are ischemic,1 caused by a blockage of blood flow to the brain, and approximately 46% of these are large-vessel occlusions,2 with poor outcomes and high mortality. This is why Stryker introduced the Trevo XP ProVue Retriever, a fourth-generation Trevo product that is designed to capture and remove the clots and restore blood flow to the brain. The Trevo XP ProVue Retriever is just one example of Stryker’s commitment to provide complete stroke care for patients.
1 American Heart Association. “Heart Disease and Stroke Statistics — 2012 Update.” Dallas, Texas: American Heart Association, 2012. ©2012, American Heart Association.
2 Smith, et al. “Significance of Large Vessel Intracranial Occlusion Causing Acute Ischemic Stroke and TIA.” Stroke, 2009 40:3834–3840.
sales team exceeded
$100 million in sales.
Stryker is dedicated to providing innovative products and outstanding service to foot and ankle surgeons around the world. Our comprehensive portfolio includes plating, external fixation, nailing, screws and Memometal nitinol products. These products reflect our commitment to improve patients’ lives, as we continue to partner with surgeons to drive innovation, education and research. Because of this commitment, our sales team in Foot & Ankle exceeded $100 million in sales in 2013, making Stryker the fastest growing business in the U.S. foot and ankle market.
We have 25,000+ employees around the world and sell products in more than 100 countries. Because of the diversity of our operations, we understand local needs and build strong working relationships with our customers. By having dedicated employees closely involved in day-to-day activities and by helping our customers deliver optimal care for their patients in each market, we have a formidable platform to accelerate global growth.
Our acquisition of Trauson Holdings Company Limited, in 2013, is a critical step toward broadening our presence in China and developing a platform for the growing value segment of the Chinese orthopaedic market, as well as for other emerging markets. A well-established brand, Trauson is the leading trauma manufacturer in China and a major competitor in the spine segment. The combined scale, local and global expertise, complementary product offerings and market breadth of Trauson and Stryker create significant competitive advantages and underscore Stryker’s commitment to strengthening its presence globally.
is a compelling opportunity
to drive growth in China.
Carlos had severely bowed legs as a small child, a result of achondroplasia, a common form of dwarfism. His parents agreed to a surgical intervention that would elongate his legs. “The most appropriate moment to start is as a pre-teen, when the bones and soft tissue have sufficient elasticity,” says Dr. Ignacio Ginebreda, an expert at the Clinic Dexeus in Barcelona, Spain. “Most patients complete the process in three or four years.” Carlos, who is now 19 and studying communications in college, has been able to live a more active and socially integrated life.
Stryker’s Triax Blue monolateral external fixators are used to lengthen the tibia, and Triax Yellow can be used for small tibia elongation.
“The goal is to improve the quality of life for people suffering from achondroplasia.”
—Dr. Ignacio Ginebreda
Stryker’s global supply chain is not just about warehousing and distribution. Today, it’s a highly coordinated network of resources — including products from seven divisions — with software designed to improve service, reduce costs (Stryker saved $18 million in 2013) and provide a consistently high standard of quality. In addition to our new central distribution center in Indianapolis, we now have systems that analyze shipping data and streamline deliveries in unique ways to help customers save money. Our Venlo facility in the Netherlands now supports Europe, Eastern Europe, the Middle East & Africa, and provides an order management system for our global neurovascular business.
PIECES RECEIVED AND SHIPPED THROUGH INDIANAPOLIS AND VENLO FACILITIES
Together with our customers, we are driven to make healthcare better. This simple sentence is not only our mission, it also reflects our values. There’s never been a time when collaboration with our customers to help guide our investment in innovative products and services has been more important.
Reduction in equipment costs
Reduction in O.R. Downtime
INCREASE in TOOL LIFE SPAN
Have more time and energy for patient care
Receive better in‑servicing and equipment training
Maximizing capital investments is more important than ever in today’s cost-conscious healthcare environment. To meet this need, our ProCare business provides maintenance, service and workflow services that can maximize the life and value of our customers’ capital investments, minimize operating costs and help to improve patient outcomes. Survey data indicates that our ProCare service saved customers 28% on equipment repair costs, reduced operating room downtime by 57% and increased equipment life by 94%. With such results, our ProCare service offering is helping us to solve customer problems, and to build and maintain deeper relationships.
Implants are specifically designed for each patient from CT data.
“I only wish I had the ability to go back and perform hundreds of surgeries with this technology.”
—Dr. William P. Magee, Jr., D.D.S., M.D.
Sarah was born with a form of Crouzon’s Syndrome, a genetic disorder characterized by the premature fusion of certain skull bones, which prevents the skull from growing normally, affecting the shape of the head and face and potentially causing developmental delays. During a recent surgery, Sarah received our MEDPOR Customized Implants, made from a biocompatible material designed to correct defects in the maxillofacial or craniofacial bone and allow for fibrovascular in-growth and patient-tissue integration. Since her surgery, Sarah’s appearance has improved dramatically, and she is progressing well and becoming more sociable.
Our Performance Solutions group is dedicated to helping hospitals and physician groups achieve their clinical, operational and financial performance goals. By analyzing metrics and optimizing services and systems, we help customers improve patient outcomes and increase efficiencies. Our teams implement improvements for such key indicators as length of stay, readmissions, patient and surgeon satisfaction, treatment complications, volume, healthcare reform strategies, and the alignment of hospitals and physicians. A recent example of this work: the creation of the Center for Advanced Recovery, a designated network of high-performing facilities for joint replacement and spine, reflecting a stringent measuring process, high standards and results.
We offer a patient-centric model across the care continuum with a focus on care coordination and patient and family education. The goal is to improve patient satisfaction, which can increase word-of-mouth referrals and volume and improve reputation.
With higher-quality outcomes, which can include reducing length of stay, readmissions and complications, as well as increasing volume, hospitals can improve payor reimbursements.
Focusing on both physician and provider economics, we are helping to increase volume and reduce costs through a standardized care model and process improvements, which can drive better alignment and help customers thrive through healthcare reform.
